CERT

Certara Inc

May 19 • 01:14PM ET

4.64

+0.08 1.64 %

Healthcare • Health Information Services • USA • Small • NASD

| Held by: IJR VTI VB FXH VXF VBR SPSM DFAT VBK DFSV

Index	-	P/E	-	EPS (ttm)	-0.10	Insider Own	31.33%	Shs Outstand	153.33M	Perf Week	-8.94%
Market Cap	721.04M	Forward P/E	11.21	EPS next Y	0.41	Insider Trans	0.00%	Shs Float	106.83M	Perf Month	-25.12%
Enterprise Value	875.52M	PEG	2.36	EPS next Q	0.09	Inst Own	82.18%	Short Float	22.58%	Perf Quarter	-29.02%
Income	-15.10M	P/S	1.72	EPS this Y	-13.01%	Inst Trans	-6.40%	Short Ratio	6.29	Perf Half Y	-44.36%
Sales	419.75M	P/B	0.70	EPS next Y	8.01%	ROA	-0.99%	Short Interest	24.12M	Perf YTD	-47.39%
Book/sh	6.63	P/C	4.82	EPS next 5Y	4.76%	ROE	-1.44%	52W High	13.88 -66.61%	Perf Year	-60.65%
Cash/sh	0.96	P/FCF	8.11	EPS past 3/5Y	- 50.19%	ROIC	-1.15%	52W Low	4.45 4.16%	Perf 3Y	-76.94%
Dividend Est.	-	EV/EBITDA	9.04	Sales past 3/5Y	7.66% 11.45%	Gross Margin	47.97%	Volatility	7.10% 5.84%	Perf 5Y	-81.87%
Dividend TTM	-	EV/Sales	2.09	EPS Y/Y TTM	-477.58%	Oper. Margin	5.06%	ATR (14)	0.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	6.40%	Profit Margin	-3.60%	RSI (14)	28.22	Recom	2.23
Dividend Gr. 3/5Y	- -	Current Ratio	1.88	EPS Q/Q	-289.12%	SMA20	-18.57%	Beta	1.49	Target Price	7.62
Payout	-	Debt/Eq	0.30	Sales Q/Q	0.86%	SMA50	-21.62%	Rel Volume	0.53	Prev Close	4.56
Employees	1576	LT Debt/Eq	0.29	Earnings	May 11 BMO	SMA200	-47.67%	Avg Volume	3.84M	Price	4.64
IPO	Dec 11, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.41% 0.74%	Trades		Volume	1,207,033	Change	1.64%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Overweight → Equal Weight	$8
Feb-27-26	Downgrade	Craig Hallum	Buy → Hold	$10
Jan-06-26	Upgrade	Leerink Partners	Market Perform → Outperform	$13
Nov-21-25	Initiated	Rothschild & Co Redburn	Buy	$10
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$9
Sep-29-25	Initiated	Craig Hallum	Buy	$16
Jul-03-25	Resumed	Morgan Stanley	Equal-Weight	$16
May-08-25	Upgrade	Barclays	Equal Weight → Overweight	$14
Feb-27-25	Initiated	TD Cowen	Buy	$16
Sep-27-24	Upgrade	UBS	Neutral → Buy	$16
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$23
Apr-04-24	Initiated	JMP Securities	Mkt Perform
Feb-26-24	Initiated	Leerink Partners	Market Perform	$19
Dec-07-23	Initiated	UBS	Neutral	$17
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold	$24.50 → $17
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight	$28
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$17 → $19

Show Previous Ratings

May-18-26 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-26 03:03AM	Certara Inc (CERT) Q1 2026 Earnings Call Highlights: Navigating Modest Growth and Strategic ... (GuruFocus.com)
May-11-26 10:17AM	Certara (CERT) Shares Slide After Weak Full-Year Guidance Overshadows Revenue Beat (InvestorsHub) -18.70%
06:25AM	Certara Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-07-26 08:00AM	Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development (Business Wire)
07:00AM	Loading…
Apr-22-26 07:00AM	Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat (GlobeNewswire)
Apr-09-26 04:15PM	Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 (GlobeNewswire)
Mar-07-26 11:02PM	Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference (MarketBeat)
Mar-03-26 08:00AM	Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib (GlobeNewswire)
Feb-27-26 08:30AM	Certara, Inc. Q4 2025 Earnings Call Summary (Moby)
08:30AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-26-26 04:08PM	Certara Inc (CERT) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
12:06PM	Certara Q4 Earnings Call Highlights (MarketBeat)
08:15AM	Certara, Inc. (CERT) Q4 Earnings Lag Estimates (Zacks)
06:00AM	Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance (GlobeNewswire)
02:56PM	Loading…
Feb-10-26 02:56PM	Analyst Sentiment on Certara (CERT) Remains Moderately Bullish Despite Sector Volatility (Insider Monkey)
Jan-29-26 08:30AM	Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 (GlobeNewswire)
Jan-27-26 07:38AM	Lower-Than-Expected Service Bookings Impacted Certara (CERT) in Q4 (Insider Monkey)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire)
Dec-11-25 06:00AM	Certara Appoints Jon Resnick as Chief Executive Officer (GlobeNewswire) -5.06%
Dec-09-25 03:33PM	Do Options Traders Know Something About CERT Stock We Don't? (Zacks)
Dec-08-25 12:20PM	Earnings Estimates Moving Higher for Certara (CERT): Time to Buy? (Zacks)
09:55AM	Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet (Zacks)
Nov-07-25 12:13AM	Certara Inc (CERT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Booking Challenges (GuruFocus.com) -23.07%
Nov-06-25 06:55PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks)
04:15PM	Certara Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 10:00AM	Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
08:00AM	Certara Automates Scientific Workflows with Phoenix Cloud (GlobeNewswire)
Oct-31-25 08:00AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-30-25 04:15PM	Certara Expands Biosimulation Market with AI-Driven QSP Platform (GlobeNewswire)
10:00AM	Loading…
10:00AM	Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-20-25 08:00AM	Certara Scientists are Among the Topmost Cited Biopharma Researchers (GlobeNewswire)
Oct-10-25 08:00AM	Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 (GlobeNewswire) -8.35%
Oct-02-25 09:13AM	Can Doximity's New AI Suite Drive the Growth It Needs? (Zacks)
Sep-04-25 08:00AM	Certara Launches Pinnacle 21 Enterprise Plus to Deliver Regulatory Submissions Faster (GlobeNewswire)
Sep-02-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-25 03:28PM	Certara, Inc. (CERT): A Bull Case Theory (Insider Monkey) +18.15%
Aug-06-25 06:00PM	Certara, Inc. (CERT) Q2 Earnings Miss Estimates (Zacks)
04:15PM	Certara Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 02:00AM	Certara Simcyp Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling (GlobeNewswire)
Jul-31-25 04:15PM	Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform (GlobeNewswire)
10:00AM	Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-30-25 10:00AM	Certara, Inc. (CERT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-29-25 08:25AM	Alkermes (ALKS) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-18-25 08:38AM	Do Options Traders Know Something About Certara Stock We Don't? (Zacks)
Jul-15-25 01:56PM	Simulations Plus Sees Weaker Demand Persist, Outlook Softens (Benzinga) -6.55%
Jul-11-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-10-25 12:39AM	Morgan Stanley Assumes Coverage of Certara (CERT) Stock (Insider Monkey)
Jul-09-25 04:15PM	Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 (GlobeNewswire)
Jul-08-25 12:05PM	VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait? (Zacks)
08:00AM	Certara Announces Expansion of Clinical Technology Collaboration with Merck (GlobeNewswire)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-20-25 08:25AM	Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS? (Zacks)
May-23-25 09:17AM	AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge (PR Newswire)
May-06-25 08:31AM	Q1 2025 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -11.03%
03:09AM	Certara Inc (CERT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-05-25 07:22PM	Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:45PM	Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	Certara Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
10:01AM	Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-28-25 10:00AM	Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-21-25 08:00AM	3 Momentum Stocks That Could Soar Post-Market Volatility (MarketBeat)
Apr-16-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-15-25 12:40AM	Why Certara Inc. (CERT) Skyrocketed On Monday? (Insider Monkey)
Apr-14-25 08:15AM	Certara Launches Non-Animal Navigator Solution to Help Drug Developers Reduce Reliance on Animal Testing (GlobeNewswire) +11.54%
08:00AM	Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization (GlobeNewswire)
Apr-12-25 06:45PM	Why Certara Inc. (CERT) Soared Last Week? (Insider Monkey)
02:10AM	Why Certara Inc. (CERT) Surged On Friday? (Insider Monkey)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +22.84%
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)
Apr-02-25 12:49PM	Checking Back In On Certara: Unattractive Valuation (Seeking Alpha)
Apr-01-25 08:00AM	Certara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities (GlobeNewswire)
Mar-06-25 07:58PM	Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Mar-05-25 04:15PM	Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions (GlobeNewswire)
Feb-27-25 07:59AM	Q4 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:28AM	Certara Inc (CERT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Feb-26-25 06:45PM	Certara, Inc. (CERT) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Certara Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Feb-14-25 01:12PM	Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey)
Jan-29-25 04:15PM	Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-24-25 12:48PM	Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerinks Target Price Boost to $13 (Insider Monkey)
Jan-15-25 07:55AM	Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) +11.36%
Jan-02-25 04:15PM	Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.16%
Dec-06-24 10:02AM	Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 (Insider Monkey)
Dec-02-24 04:15PM	Certara Showcases 2024 Research Wins With Over 100 Papers Published (GlobeNewswire)
Nov-13-24 09:29AM	Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 (Insider Monkey)
Nov-07-24 10:38AM	Q3 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:27AM	Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-06-24 07:05PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks) +5.82%
04:15PM	Certara Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-28-24 04:15PM	Certara to Participate in the Stephens Annual Investment Conference (GlobeNewswire)
Oct-16-24 04:15PM	Certara Appoints John Reynders as New Independent Board Member (GlobeNewswire)
Oct-15-24 08:05AM	MaxCyte Appoints Cynthia Collins to its Board of Directors (GlobeNewswire)
Oct-09-24 04:15PM	Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024 (GlobeNewswire)
Oct-02-24 04:15PM	Certara Completes Acquisition of Chemaxon (GlobeNewswire)
Sep-27-24 07:20PM	Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon (CNBC TV) +9.81%
Sep-24-24 08:00AM	Certara's Simcyp Consortium Celebrates 25th Anniversary (GlobeNewswire)
Sep-18-24 08:00AM	Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug (GlobeNewswire)
Sep-17-24 11:02AM	Should You Increase Your Holdings in Certara (CERT)? (Insider Monkey)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

President & Chief Commercial OfficerMr. Leif E. Pedersen

SVPMr. John E. Gallagher III

President of Certara Predictive TechnologiesDr. Robert P. Aspbury Ph.D.

President of Drug Development SolutionsDr. Adrian K. McKemey Ph.D.

CEO & DirectorMr. Jon Resnick

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Collins Cynthia	Director	May 14 '26	Option Exercise	0.00	15,757	0	51,846	May 15 04:31 PM
Reynders John V W	Chief Financial Officer	May 14 '26	Option Exercise	0.00	15,757	0	26,466	May 15 04:29 PM
BROSHY ERAN	Chairman	May 14 '26	Option Exercise	0.00	15,757	0	50,708	May 15 04:28 PM
Bedi Arjun	Director	May 14 '26	Option Exercise	0.00	5,547	0	5,547	May 15 04:28 PM
CASHMAN JAMES E III	Chairman	May 14 '26	Option Exercise	0.00	15,757	0	484,197	May 15 04:27 PM
Killefer Nancy	Director	May 14 '26	Option Exercise	0.00	15,757	0	51,846	May 15 04:26 PM
Crane Rosemary A	Director	May 14 '26	Option Exercise	0.00	15,757	0	45,672	May 15 04:26 PM
WALSH MATTHEW M	Director	May 14 '26	Option Exercise	0.00	15,757	0	213,316	May 15 04:25 PM
Resnick Jon Matthew	Chief Executive Officer	May 11 '26	Option Exercise	0.00	59,766	0	59,766	May 13 04:53 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '26	Option Exercise	0.00	33,167	0	113,744	Apr 03 04:11 PM
McKemey Adrian	President, Drug Dev. Solutions	Apr 01 '26	Option Exercise	0.00	10,849	0	10,849	Apr 03 04:10 PM
Corcoran Daniel	SVP and General Counsel	Apr 01 '26	Option Exercise	0.00	10,849	0	27,070	Apr 03 04:09 PM
Gallagher John E	Chief Financial Officer	Apr 01 '26	Option Exercise	0.00	50,605	0	103,174	Apr 03 04:07 PM
Aspbury Robert	PRESIDENT, PREDICTIVE TECH	Apr 01 '26	Option Exercise	0.00	33,167	0	339,581	Apr 03 04:06 PM
Anhalt Rona	Chief Human Resources Officer	Apr 01 '26	Option Exercise	0.00	9,764	0	14,945	Apr 03 04:04 PM
Feehery William F	CHIEF EXECUTIVE OFFICER	Nov 11 '25	Buy	8.30	24,096	200,000	2,360,769	Nov 12 04:44 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Sep 09 '25	Sale	10.92	51,224	559,366	73,979	Sep 11 04:47 PM
Pedersen Leif E	Officer	Sep 09 '25	Proposed Sale	10.92	51,224	559,304		Sep 09 04:16 PM
Anhalt Rona	Chief Human Resources Officer	May 30 '25	Option Exercise	0.00	7,146	0	7,146	Jun 02 04:58 PM
Corcoran Daniel	SVP and General Counsel	May 30 '25	Option Exercise	0.00	22,828	0	20,530	Jun 02 04:57 PM
WALSH MATTHEW M	Director	May 21 '25	Option Exercise	0.00	11,928	0	197,559	May 22 05:07 PM
Reynders John V W	Director	May 21 '25	Option Exercise	0.00	10,709	0	10,709	May 22 05:05 PM
Killefer Nancy	Director	May 21 '25	Option Exercise	0.00	11,928	0	36,089	May 22 05:04 PM
Crane Rosemary A	Director	May 21 '25	Option Exercise	0.00	11,928	0	29,915	May 22 05:03 PM
Collins Cynthia	Director	May 21 '25	Option Exercise	0.00	11,928	0	36,089	May 22 05:01 PM
CASHMAN JAMES E III	Chairman	May 21 '25	Option Exercise	0.00	11,928	0	468,440	May 22 05:00 PM
BROSHY ERAN	Chairman	May 21 '25	Option Exercise	0.00	11,928	0	34,951	May 22 04:58 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERT

Certara Inc

Upgrade your Finviz experience